Nile Pharmaceuticals

مادة اعلانية

Latest Update: 13 Jan 2026 14:02 Abu Dhabi Time.

Market Status: Opened

NIPH

Nile Pharmaceuticals

100.03

EGP

-1.360

-1.34%

Open

101.39

Prev Close

101.39

PX_VOLUME

100,071

MARKET CAP (M)

DAY RANGE

99.50 - 101.85

52 WEEKS

29.29 - 149.50

Stock Statistics

Yearly Change

184.26%

Listed Shares (Million)

50.00

Earnings Multiple

19.49

Average 30-day trading volume

192,882.51

Price-to-book ratio

4.85

Earnings Per Share

2.79

Previous Dividend Distribution

4.25

Dividend Yield

7.75%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		681.20	321.34		121.77	79.23	296.69	387.93	378.73
Gross Profit		211.36	107.41		34.81	-22.98	66.54	99.51	109.37
Operating Income		183.81	77.71		12.05	-45.43	42.77	64.98	81.19
Profit Margin		15.64	0.33		-9.64	-40.59	8.89	10.87	14.22

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Revenue		1,289.58	1,142.58	1,005.22	876.78	755.51
Gross Profit		407.81	252.43	271.81	222.34	201.08
Operating Income		288.74	143.52	162.76	125.44	95.60
Profit Margin		9.75	7.90	11.86	10.23	8.53

Balance Sheet

	Period Ending:	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		3,673.14	2,320.71	1,985.65	1,568.73	1,473.19	1,420.28	1,201.86	1,106.13
Total Liabilities		2,623.33	1,577.42	1,243.43	1,111.61	1,004.34	905.13	710.54	573.80
Total Equity		1,049.81	743.29	742.22	457.12	468.86	515.14	491.33	532.32

	Period Ending:	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Assets		2,320.71	1,473.19	1,038.29	769.38	720.14
Total Liabilities		1,577.42	1,004.34	559.81	338.52	348.82
Total Equity		743.29	468.86	478.48	430.87	371.32

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.